PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2012

From popular use to pharmacological validation: a study of the anti-inflammatory, anti-nociceptive and healing effects of Chenopodium ambrosioides extract.

Mixed / Wound

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 23123797 ↗2012Reported benefit

From popular use to pharmacological validation: a study of the anti-inflammatory, anti-nociceptive and healing effects of Chenopodium ambrosioides extract.

MixedWoundmaleOral and topical150 to 500 mg/kg orally; topical 1%, 3% and 5%Administered in acute pain, oedema and wound models; topical extract applied to…

Model: Excision wound model in rats, with carrageenan, prostaglandin E2, substance P and bradykinin induced paw oedema, croton oil, arachidonic acid and capsaicin induced ear oedema, carrageenan pleurisy and formalin nociception in mice

Topical 5% extract reduced ear oedema by 70.85 to 78.09% and oral 500 mg/kg reduced paw oedema by 40 to 57%, leucocyte influx by 78%, nitric oxide by 77.77% and TNF-alpha by 50%, inhibited nociception, and topical 5% significantly reduced excision wound area without altering motor performance.

Extraction: extract · Supplied extraction confidence: 0.78. Machine-extracted fields require source verification.